Avalo Therapeutics, Inc.

AVTXNASDAQHealthcareBiotechnology

$6.93- (-)1Y −58.43%

As of Oct 23, 2026 close

Market cap: $302.16M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $11.21$24.27
Volume (live): -
Avg. volume (3M): 2.09M

Avalo Therapeutics, Inc. (AVTX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Avalo Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy

Based on 6 unique analysts

(10 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$34.17

+393.07% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest AVTX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 23, 2026	Robert Driscoll	Wedbush	Reiterates	Buy	$34.00 → $22.00 −12.00 (−35.3%)
Oct 23, 2026	Mitchell Kapoor	HC Wainwright	Downgrades	Hold	$30.00
Oct 23, 2026	Julian Harrison	BTIG	Maintains	Buy	$58.00 → $10.00 −48.00 (−82.8%)
Oct 15, 2026	Mitchell Kapoor	HC Wainwright	Reiterates	Buy	$30.00
Oct 1, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$60.00
Aug 7, 2026	Yatin Suneja	Guggenheim	Reiterates	Buy	$50.00 → $48.00 −2.00 (−4.0%)
Aug 7, 2026	Mitchell Kapoor	HC Wainwright	Reiterates	Buy	$35.00 → $30.00 −5.00 (−14.3%)
Aug 7, 2026	Julian Harrison	BTIG	Maintains	Buy	$58.00
Aug 7, 2026	Alec Stranahan	BofA Securities	Reiterates	Buy	$35.00
Aug 6, 2026	Yatin Suneja	Guggenheim	Reiterates	Buy	$50.00 → $48.00 −2.00 (−4.0%)

Robert Driscoll

Wedbush

BuyReiterates

$34.00 → $22.00

Oct 23

Mitchell Kapoor

HC Wainwright

HoldDowngrades

$30.00

Oct 23

Julian Harrison

BTIG

BuyMaintains

$58.00 → $10.00

Oct 23

Mitchell Kapoor

HC Wainwright

BuyReiterates

$30.00

Oct 15

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$60.00

Oct 1

Yatin Suneja

Guggenheim

BuyReiterates

$50.00 → $48.00

Aug 7

Mitchell Kapoor

HC Wainwright

BuyReiterates

$35.00 → $30.00

Aug 7

Julian Harrison

BTIG

BuyMaintains

$58.00

Aug 7

Alec Stranahan

BofA Securities

BuyReiterates

$35.00

Aug 7

Yatin Suneja

Guggenheim

BuyReiterates

$50.00 → $48.00

Aug 6

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 23, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for AVTX?

The analyst consensus rating for AVTX is Buy, based on the latest ratings from 6 analysts over the last 90 days.

What is the average price target for AVTX?

The average 12-month price target for AVTX is $34.17, representing an upside of 393.1% from the Oct 23, 2026 close of $6.93.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.